fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Miconazole nitrate

All products: general benefit

Micatin · DIN 02085852 · 2% · Cr

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Micatin · DIN 02085852 Manufacturer: WellSpring Pharmaceutical Canada Corp.; listing date 1996-10-01 Health Canada: Marketed since 2021-09-10 · brand MICATIN MICONAZOLE NITRATE CREAM 2% USP · ATC D01AC02 MICONAZOLE · form Cream · route Topical · ingredients MICONAZOLE NITRATE 2 %/W/W · company Wellspring pharmaceutical canada corp · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Micatin: Formulary list price $0.30 per unit (the source does not state the unit; exact figure $0.2970). What the ministry pays, not the patient.

Ministry pays: $0.2970 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02085852)

Source record
DIN 02085852: Micatin Raw flags: sec3=Y Item: 840408015; group id 822; item number 2004; lccId None; manufacturer id WEL Source form: Cr; strength: 2% Recorded listing: General benefit Source prices (unrounded): $0.2970; ministry $0.2970 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02085852 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16609
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02085852
Shortage record checked October 6, 2026

Other products in the same Health Canada class (D01A, D01AC): coverage varies; not interchangeable

  • Clotrimazole (Clotrimaderm): general benefit, not a benefit
  • Ketoconazole (Nizoral): general benefit, not a benefit
  • Betamethasone dipropionate + clotrimazole (Lotriderm Cream): not a benefit
  • Nystatin (Mycostatin): general benefit, not a benefit
  • Terbinafine (Lamisil): general benefit
  • Ciclopirox (Penlac): not a benefit
Other drugs in the same formulary class (84:04:08 Fungicides) and how they are covered

Matched class: 84:04:08 Fungicides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: TERBINAFINE HCL Some products covered without a code (check the product listing): CLOTRIMAZOLE, KETOCONAZOLE, NYSTATIN, TERCONAZOLE 84:04:08 Fungicides

CLOTRIMAZOLE

· 7 products · General benefit (6), Listed, not a benefit (1) · strengths: 10mg/g, 500mg & 1%, 20mg/g · Cr, Tab & Cr, Vag Cr-App

KETOCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Cr

CLOTRIMAZOLE & BETAMETHASONE DIPROPIONATE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% w/w & 0.05% w/w · Top Cr

NYSTATIN

· 7 products · Listed, not a benefit (3), General benefit (4) · strengths: 100000U/g, 25000U/g · Cr, Oint, Vag Cr

TERBINAFINE HCL

· 1 products · General benefit · strengths: 1% · Cr

CICLOPIROX

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8% W/W · Top Sol

TERCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.4% · Vag Cr

FLUCONAZOLE

· 9 products · Limited Use, codes 235 · strengths: 150mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:08
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Micatin® is indicated for the topical treatment of dermatophytes and Candida infections and also lesions caused by mixed infections involving susceptible fungi. It has been clinically effective in treating tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), and tinea versicolor (fungal infection of the skin) caused by dermatophytes. 3 Micatin® is also effective in cutaneous candidiasis (skin infections caused by candida fungi), excluding moderate to severe candidal paronychia (inflammation and infection of the nail folds caused by candida fungi). Among the organisms against which Micatin® has been found effective are Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton interdigitale, Epidermophyton floccosum, Microsporum canis, Microsporum gypseum, species of Candida including C. Albicans, and Malassezia furfur. https://pdf.hres.ca/dpd_pm/00056599.PDF PM date: not printed or not captured Source product: MICATIN MICONAZOLE NITRATE CREAM 2% USP; DIN 02085852; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.